YONGHE MEDICAL GROUP CO., LTD. Financials Yonghe Medical Group Co., Ltd.
Equities
2279
KYG5688E1008
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.18 HKD | -0.84% |
|
-5.60% | -53.36% |
| 03-28 | Yonghe Medical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-11 | Yonghe Medical to Widen Loss in 2023 | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 6,753 | 5,577 | 547.2 | 547.2 | - |
| Enterprise Value (EV) 2 | 6,209 | 5,634 | 1,212 | 1,462 | 1,415 |
| P/E ratio | 46.4 x | -65.5 x | -2.16 x | -3.51 x | 21.9 x |
| Yield | 0.59% | - | - | - | - |
| Capitalization / Revenue | 3.11 x | 3.95 x | 0.68 x | 0.26 x | 0.22 x |
| EV / Revenue | 2.86 x | 3.99 x | 0.68 x | 0.68 x | 0.57 x |
| EV / EBITDA | 13.6 x | 89.4 x | -5.44 x | 63.1 x | 4.77 x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Price to Book | 3.29 x | 3.52 x | 0.44 x | 0.57 x | 0.58 x |
| Nbr of stocks (in thousands) | 519,956 | 527,080 | 500,926 | 500,926 | - |
| Reference price 3 | 15.94 | 11.98 | 1.180 | 1.180 | 1.180 |
| Announcement Date | 24/03/22 | 30/03/23 | 28/03/24 | - | - |
1HKD in Million2CNY in Million3HKD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 2,169 | 1,413 | 1,777 | 2,134 | 2,487 |
| EBITDA 1 | - | 456.9 | 63.05 | -244.3 | 23.18 | 296.5 |
| EBIT 1 | - | 256.1 | -161.6 | -531.8 | -193 | 19 |
| Operating Margin | - | 11.81% | -11.44% | -29.92% | -9.04% | 0.76% |
| Earnings before Tax (EBT) 1 | - | 210.3 | -109.5 | -585.2 | -257.9 | -19.69 |
| Net income 1 | 163.3 | 120.2 | -85.86 | -546.4 | -162 | 28 |
| Net margin | - | 5.54% | -6.08% | -30.74% | -7.59% | 1.13% |
| EPS 2 | 0.4778 | 0.3438 | -0.1828 | -1.170 | -0.3360 | 0.0540 |
| Free Cash Flow | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 2 | - | 0.0934 | - | - | - | - |
| Announcement Date | 30/11/21 | 24/03/22 | 30/03/23 | 28/03/24 | - | - |
1CNY in Million2HKD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 57.6 | 783 | 915 | 868 |
| Net Cash position 1 | - | 545 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | 0.9131 x | -3.204 x | 39.45 x | 2.928 x |
| Free Cash Flow | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 11.4% | -2.61% | -19.1% | -19.4% | -1.8% |
| ROA (Net income/ Total Assets) | - | 5.01% | -2.8% | -6.1% | -8.6% | 1.4% |
| Assets 1 | - | 2,397 | 3,065 | 4,340 | 1,884 | 2,000 |
| Book Value Per Share 2 | - | 4.850 | 3.410 | 2.680 | 2.070 | 2.050 |
| Cash Flow per Share 2 | - | 1.250 | -0.2400 | 0.1700 | 0.6700 | 0.0400 |
| Capex 1 | - | 182 | 244 | 263 | - | - |
| Capex / Sales | - | 8.38% | 17.24% | 15.31% | - | - |
| Announcement Date | 30/11/21 | 24/03/22 | 30/03/23 | 28/03/24 | - | - |
1CNY in Million2HKD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
1.18
HKD
Average target price
2.4
HKD
Spread / Average Target
+103.39%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -53.36% | 76.3M | |
| -8.73% | 1.43B |
- Stock Market
- Equities
- 2279 Stock
- Financials Yonghe Medical Group Co., Ltd.
